SCHEMBL3466973

SCHEMBL3466973

Cc1ccc(N(C(=O)O)S(=O)(=O)c2cccc(C#CCBr)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
HCRTR2 O43614 3/20 0.40
KMT2A Q03164 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
TP53 P04637 4/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 4/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
THRB P10828 1/20 0.38
GAA P10253 2/20 0.37
TSHR P16473 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008265 0.91 LMNA (0.41) CA12CA1CA2CA9KMT2A
SCHEMBL1860642 0.85 CA12 (0.38) CA12CA1CA2CA9HCRTR2
SCHEMBL4007168 0.85 PTGDR2 (0.43) CA12CA1CA2CA9HCRTR2
SCHEMBL4015477 0.81 PTGDR2 (0.45) CA12CA1CA2CA9KMT2A
SCHEMBL4014559 0.80 LMNA (0.41) CA12CA1CA2CA9KMT2A
SCHEMBL1855707 0.78 F2 (0.40) CA12CA1CA2CA9KMT2A
SCHEMBL1856336 0.78 KMT2A (0.48) HCRTR2KMT2ATP53ALDH1A1POLB
SCHEMBL3467601 0.77 KMT2A (0.43) CA12CA1CA2CA9KMT2A
SCHEMBL4014515 0.75 PTGDR2 (0.41) CA12CA1CA2CA9HCRTR2
SCHEMBL1860465 0.72 PTGDR2 (0.38) CA12CA1CA2CA9HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed